Summary & Overview
HCPCS Level II J2270: Injection, Morphine Sulfate, Up to 10 mg
HCPCS Level II code J2270 represents an injection of morphine sulfate, up to 10 mg, used for parenteral management of acute or severe pain. This code is important nationally because morphine remains a commonly used opioid analgesic in emergency, perioperative, and inpatient care settings, and accurate coding affects clinical documentation, pharmacy billing, and opioid utilization tracking. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical context for using J2270, typical sites of service where the injection is administered, and distinctions with closely related codes (for example, preservative-free formulations). The publication outlines common diagnostic contexts for use—such as unspecified pain, neoplasm-related pain, low back pain, chest pain, and abdominal pain—and summarizes related coding considerations and billing practice implications. It also provides benchmarking and policy-focused content: payer coverage patterns, reimbursement considerations, and code-to-code guidance to help payers and providers align billing with clinical documentation. This summary is intended for a national audience including hospital billers, pharmacy billing teams, revenue cycle managers, and policy analysts.
Billing Code Overview
HCPCS Level II code J2270 describes an injection of morphine sulfate, up to 10 mg. The service represents a parenteral opioid analgesic administration typically provided for acute or severe pain management. The service type is an injectable opioid analgesic. The typical site of service is outpatient or inpatient clinical settings where parenteral analgesia is administered, such as emergency departments, hospital inpatient units, ambulatory surgery centers, and physician offices.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient presents to the emergency department with acute exacerbation of chronic cancer-related pain and reports severe uncontrolled back pain. The emergency medicine physician performs assessment, documents pain severity and previous opioid use, and orders an immediate parenteral opioid for rapid analgesia. A nurse or clinician prepares and administers J2270 (injection, morphine sulfate, up to 10 mg) intravenously or intramuscularly as indicated. The medication is documented in the medication administration record with dose, route, time, and patient response. Monitoring for respiratory status, level of consciousness, and hemodynamics occurs for the required observation period following administration. If the patient requires a preservative-free preparation, J2274 would be used instead of J2270. Typical sites of service include the emergency department, hospital inpatient unit, observation unit, or outpatient clinics providing urgent analgesia. Documentation supporting medical necessity includes the presenting diagnosis (for example G89.3, M54.5, R52), assessment of pain level, prior analgesic regimen, informed consent when applicable, and objective monitoring after administration.
Coding Specifications
| Modifier | Description | When to Use |
|---|